What is Cytosorbents Crp (CTSO) stock price today?

Cytosorbents Crp (CTSO) currently trades at $0.57 per share. The stock has a market capitalization of $38.95M and a P/E ratio of —x.

Is CTSO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cytosorbents Crp has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Cytosorbents Crp's revenue and earnings?

Cytosorbents Crp has trailing twelve-month (TTM) revenue of $37.06M with profit margins of -22.10%. Earnings per share (EPS) is $-0.13.

CTSO

Cytosorbents Crp

NASDAQ: CTSO · HEALTHCARE · MEDICAL DEVICES

$0.57

-5.80% today

Updated 2026-05-06

Market cap

$38.95M

P/E ratio

—

P/S ratio

1.05x

EPS (TTM)

$-0.13

Dividend yield

—

52W range

$1 – $1

Volume

0.1M

Market cap

$38.95M

P/E ratio

—

P/S ratio

1.05x

EPS (TTM)

$-0.13

Dividend yield

—

52W range

$1 – $1

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.0

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$5.25

+821.05%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at -22.10%

- Negative free cash flow $-4.89M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$34.69M	$31.08M	$35.59M	$37.06M	$37.06M
Net income	$-32.81M	$-29.25M	$-20.72M	$-8.20M	$-5.50M
EPS	—	—	—	—	$-0.13
Free cash flow	$-34.69M	$-22.59M	$-14.71M	$-12.54M	$-4.89M
Profit margin	-94.59%	-94.09%	-58.21%	-22.12%	-22.10%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CTSO	$38.95M	22	4.0	2.0	5.0	5.0	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

Cytosorbents Crp trades at $0.57. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $37.06M. with profit margins at -22.10%.

Frequently asked questions

What is Cytosorbents Crp's stock price?

Cytosorbents Crp (CTSO) trades at $0.57.

Is Cytosorbents Crp overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Cytosorbents Crp (CTSO)?

The analyst target price is $5.25, representing +821.1% upside from the current price of $0.57.

What is Cytosorbents Crp's revenue?

TTM revenue is $37.06M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.05x

ROE-96.40%

Beta1.44

50D MA$0.66

200D MA$0.78

Shares out0.06B

Float0.05B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CTSO vs LLY →CTSO vs JNJ →CTSO vs ABBV →Stock screener →